To assess the role of IL-2 in pancreatic ductal adenocarcinoma (PDAC), we compared the levels of IL-2 in tumors from 178 PDAC patients obtained from the TCGA portal with 171 normal pancreases from the GTEx portal. Here, IL2 is linked to pancreatic ductal adenocarcinoma.